Anna Rutherford1, Lindsay Y King2, Linda S Hynan3, Chetan Vedvyas4, Wenyu Lin5, William M Lee6, Raymond T Chung7. 1. Department of Internal Medicine, Brigham & Women's Hospital, Boston, MA; Division of Gastroenterology, Hepatology & Endoscopy, Brigham & Women's Hospital, Boston, MA. 2. Department of Internal Medicine, Brigham & Women's Hospital, Boston, MA; Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA. 3. Departments of Clinical Sciences (Division of Biostatistics) and Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX. 4. Harvard Medical School, Boston, MA. 5. Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA. 6. Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX. 7. Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA. Electronic address: RTChung@partners.org.
Abstract
BACKGROUND & AIMS:Patients with acute liver failure (ALF) have high mortality and frequently require liver transplantation (LT); few reliable prognostic markers are available. Levels of M30, a cleavage product of cytokeratin-18 caspase, are significantly increased in serum samples from patients with ALF who die or undergo LT. We developed a prognostic index for ALF based on level of M30 and commonly measured clinical variables (called the Acute Liver Failure Study Group [ALFSG] index) and compared its accuracy with that of the King's College criteria (KCC) and Model for End Stage Liver Disease (MELD). We also validated our model in an independent group of patients with ALF. METHODS:Serum levels of M30 and M65 antigen (the total cytokeratin-18 fragment, a marker of apoptosis and necrosis) were measured on 3 of the first 4 days following admission of 250 patients with ALF. Logistic regression was used to determine whether the following factors, measured on day 1, were associated with LT or death: age, etiology; coma grade; international normalized ratio (INR); serum pH; body mass index; levels of creatinine, bilirubin, phosphorus, arterial ammonia, and lactate; andlog(10) M30 and log(10) M65. The area under the receiver operating characteristic (AUROC) was calculated for the ALFSG and other indices. RESULTS:Coma grade, INR, levels of bilirubin and phosphorus, and log(10) M30 value at study entry most accurately identified patients who would require LT or die. The ALFSG index identified these patients with 85.6% sensitivity and 64.7% specificity. Based on comparison of AUROC values, the ALFSG Index (AUROC, 0.822) better identified patients most likely to require LT or die than the KCC (AUROC, 0.654) or MELD (AUROC, 0.704) (P = .0002 and P = .0010, respectively). We validated these findings in a separate group of 250 patients with ALF. CONCLUSIONS: The ALFSG index, a combination of clinical markers and measurements of the apoptosis biomarker M30, better predicts outcomes of patients with ALF than the KCC or MELD.
RCT Entities:
BACKGROUND & AIMS:Patients with acute liver failure (ALF) have high mortality and frequently require liver transplantation (LT); few reliable prognostic markers are available. Levels of M30, a cleavage product of cytokeratin-18 caspase, are significantly increased in serum samples from patients with ALF who die or undergo LT. We developed a prognostic index for ALF based on level of M30 and commonly measured clinical variables (called the Acute Liver Failure Study Group [ALFSG] index) and compared its accuracy with that of the King's College criteria (KCC) and Model for End Stage Liver Disease (MELD). We also validated our model in an independent group of patients with ALF. METHODS: Serum levels of M30 and M65 antigen (the total cytokeratin-18 fragment, a marker of apoptosis and necrosis) were measured on 3 of the first 4 days following admission of 250 patients with ALF. Logistic regression was used to determine whether the following factors, measured on day 1, were associated with LT or death: age, etiology; coma grade; international normalized ratio (INR); serum pH; body mass index; levels of creatinine, bilirubin, phosphorus, arterial ammonia, and lactate; and log(10) M30 and log(10) M65. The area under the receiver operating characteristic (AUROC) was calculated for the ALFSG and other indices. RESULTS:Coma grade, INR, levels of bilirubin and phosphorus, and log(10) M30 value at study entry most accurately identified patients who would require LT or die. The ALFSG index identified these patients with 85.6% sensitivity and 64.7% specificity. Based on comparison of AUROC values, the ALFSG Index (AUROC, 0.822) better identified patients most likely to require LT or die than the KCC (AUROC, 0.654) or MELD (AUROC, 0.704) (P = .0002 and P = .0010, respectively). We validated these findings in a separate group of 250 patients with ALF. CONCLUSIONS: The ALFSG index, a combination of clinical markers and measurements of the apoptosis biomarker M30, better predicts outcomes of patients with ALF than the KCC or MELD.
Authors: S Strand; W J Hofmann; A Grambihler; H Hug; M Volkmann; G Otto; H Wesch; S M Mariani; V Hack; W Stremmel; P H Krammer; P R Galle Journal: Nat Med Date: 1998-05 Impact factor: 53.440
Authors: Frank V Schiødt; Lorenzo Rossaro; Richard T Stravitz; A Obaid Shakil; Raymond T Chung; William M Lee Journal: Liver Transpl Date: 2005-10 Impact factor: 5.799
Authors: Frank V Schiødt; George Ostapowicz; Natalie Murray; Raj Satyanarana; Atif Zaman; Santiago Munoz; William M Lee Journal: Liver Transpl Date: 2006-12 Impact factor: 5.799
Authors: Heike Bantel; Andreas Lügering; Jan Heidemann; Xandra Volkmann; Christopher Poremba; Christian P Strassburg; Michael Peter Manns; Klaus Schulze-Osthoff Journal: Hepatology Date: 2004-11 Impact factor: 17.425
Authors: Le H Song; Vu Q Binh; Dinh N Duy; Thomas C Bock; Peter G Kremsner; Adrian J F Luty; Elie Mavoungou Journal: J Med Virol Date: 2004-06 Impact factor: 2.327
Authors: David G Koch; Holly Tillman; Valerie Durkalski; William M Lee; Adrian Reuben Journal: Clin Gastroenterol Hepatol Date: 2016-04-13 Impact factor: 11.382
Authors: Sujith V W Weerasinghe; You-Jin Jang; Robert J Fontana; M Bishr Omary Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-06-12 Impact factor: 4.052
Authors: Benjamin L Woolbright; Mitchell R McGill; Vincent S Staggs; Robert D Winefield; Parviz Gholami; Mojtaba Olyaee; Matthew R Sharpe; Steven C Curry; William M Lee; Hartmut Jaeschke Journal: Toxicol Sci Date: 2014-09-19 Impact factor: 4.849